Triple Negative Breast Cancer Now & The Road Ahead

TNBC is more frequently diagnosed in younger, premenopausal women and is more prevalent in Black women. We must do more to ensure equitable care for Black women with #TNBC. To learn more and register to attend our first in a series of health equity initiatives click here.

We welcome all those diagnosed as well as caregivers, family and medical professionals, to join us in our 6 -part, TNBC Initiative as we provide education, awareness and partake in advocacy now to impact the future. This program is generously sponsored by Gilead Sciences.

Triple Negative Breast Cancer 101
Monday, March 21st @ 6:00 pm
Register here.

We welcome guest speaker Dr. Hadeel Assad MD, hematologist/oncologist. Dr. Assad is affiliated with the Population Studies and Disparities Research Program at Karmanos Cancer Institute. Her research interests include communication and disparities in breast cancer diagnosis and treatment. Dr. Assad is also the Associate Director of the Hematology/Oncology fellowship program at Wayne State University/Karmanos Cancer Institute and joins us to break down the specifics of a Triple Negative Breast Cancer diagnosis.

We’ll also hear from TNBC survivors and Gilda’s Club Members, Joye Mosley & Mary Carr,  sharing their stories through a different lens.

TNBC: Screening & Early Detection
Thursday, June 16th @ 6:00 pm
Register here.

Black women have 3X the risk of Triple Negative Breast Cancer, compared to white women and are more likely to be diagnosed at an advanced stage. Dr. Riddle-Jones, MD of the Breast and Cervical Cancer Control Program will shed some light on the importance of early detection and screening to drastically improve health outcomes. Dr. Darius Gilvydis, MD from Regional Medical Imaging, will also cover various breast cancer screening options and resources.

We’ll also hear from TNBC survivors and Gilda’s Club Members, Margaret Brown & Janet Stanfield, sharing their stories through a different lens.

TNBC: Clinical Trials & Research
Thursday, September 29th @ 6:00 pm
Register here.

TNBC is more frequently diagnosed in younger, premenopausal women and is more prevalent in Black women. Dr. Michael Simon MD, MPH of Karmanos Cancer Institute, joins us to discuss some of the genetic and hereditary components of TNBC that provide critical insights to treatment. We also welcome Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance to share guidance and encouragement in clinical trial participation.

We’ll hear from TNBC survivors and Gilda’s Club Members, Theresa Lawrence & Julia Fearing, sharing their stories through a different lens.

img
info@gildasclubdetroit.org
img
3517 Rochester Road Royal Oak, MI 48073
img
248.577.0800
img
Monday - Thursday: 10-8 p.m. Saturday 12-3 p.m.